Notably, eczema is a common adverse effect of anti-TNF-α therapy that has been reported in up to 20% of patients receiving long-term treatment for psoriasis, arthritis, or inflammatory bowel disease32–34. This evidence concerns the gene TNF and arthritic joint disease.